US$ 27.42
weight loss drug prescriptions semaglutide tirzepatide q3 2024 data GLP-1 prescription trends through June weight loss drug prescriptions semaglutide
Description
The Outsourcing Facilities Association, a group that represents FDA-registered compounding pharmacies known as 503Bs, filed a lawsuit against the agency on Monday in Texas, claiming the drug was still in short supply, and that agencys decision was reckless and arbitrary. It sought a temporary restraining order for 14 days that would prevent the FDA from taking action against any compounder that continues making copies of the drug
The list price for Rybelsus is $997 per month

Real-world persistence and adherence to glucagon-like peptide-1 receptor agonists among obese commercially insured adults without diabetes

Use a thermometer placed next to your medication to verify the actual temperature rather than relying on the refrigerator display

Severe or persistent abdominal pain, especially if radiating to the back and accompanied by nausea or vomiting, may indicate acute pancreatitisa serious adverse effect requiring emergency evaluation

After Week 48, participants in treatment groups 1 (placebo) and 2 (bimagrumab 10 mg/kg) switched to bimagrumab 30 mg/kg, while all other groups continued their original treatments without the placebo infusions during the 24-week open-label extension period
